131 related articles for article (PubMed ID: 17979787)
1. Cerebral acetylcholinesterase imaging: development of the radioprobes.
Kikuchi T; Okamura T; Fukushi K; Takahashi K; Toyohara J; Okada M; Zhang MR; Irie T
Curr Top Med Chem; 2007; 7(18):1790-9. PubMed ID: 17979787
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase imaging: its use in therapy evaluation and drug design.
Shinotoh H; Fukushi K; Nagatsuka S; Irie T
Curr Pharm Des; 2004; 10(13):1505-17. PubMed ID: 15134572
[TBL] [Abstract][Full Text] [Related]
3. PET probes for imaging brain acetylcholinesterase.
Kikuchi T; Okamura T; Zhang MR; Irie T
J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
[TBL] [Abstract][Full Text] [Related]
4. [Imaging of brain acetylcholinesterase activity in dementias and extrapyramidal disorders].
Shinotoh H
Rinsho Shinkeigaku; 2007 Nov; 47(11):822-5. PubMed ID: 18210807
[TBL] [Abstract][Full Text] [Related]
5. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
[TBL] [Abstract][Full Text] [Related]
6. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
[TBL] [Abstract][Full Text] [Related]
8. Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography.
Ota T; Shinotoh H; Fukushi K; Kikuchi T; Sato K; Tanaka N; Shimada H; Hirano S; Miyoshi M; Arai H; Suhara T; Irie T
Clin Neuropharmacol; 2010; 33(2):74-8. PubMed ID: 19935404
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of (-)- and (+)-[¹¹C]galanthamine as PET tracers for cerebral acetylcholinesterase imaging.
Kimura H; Kawai T; Hamashima Y; Kawashima H; Miura K; Nakaya Y; Hirasawa M; Arimitsu K; Kajimoto T; Ohmomo Y; Ono M; Node M; Saji H
Bioorg Med Chem; 2014 Jan; 22(1):285-91. PubMed ID: 24315193
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates.
Namba H; Fukushi K; Nagatsuka S; Iyo M; Shinotoh H; Tanada S; Irie T
Methods; 2002 Jul; 27(3):242-50. PubMed ID: 12183113
[TBL] [Abstract][Full Text] [Related]
11. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
[TBL] [Abstract][Full Text] [Related]
12. Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples.
Kikuchi T; Okamura T; Arai T; Obata T; Fukushi K; Irie T; Shiraishi T
Br J Pharmacol; 2010 Apr; 159(8):1732-42. PubMed ID: 20401964
[TBL] [Abstract][Full Text] [Related]
13. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
[TBL] [Abstract][Full Text] [Related]
14. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
[TBL] [Abstract][Full Text] [Related]
16. Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes.
Wang M; Wang JQ; Gao M; Zheng QH
Appl Radiat Isot; 2008 Apr; 66(4):506-12. PubMed ID: 18155915
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
